| scholarly article | Q13442814 |
| P50 | author | Michael Rak | Q57012332 |
| Felicia Goodrum | Q57649749 | ||
| Katie Caviness | Q60588235 | ||
| P2093 | author name string | Farah Bughio | |
| Mahadevaiah Umashankar | |||
| Patricia Zagallo | |||
| P2860 | cites work | Simple and highly efficient BAC recombineering using galK selection | Q24794075 |
| Decoding human cytomegalovirus | Q28279933 | ||
| An efficient recombination system for chromosome engineering in Escherichia coli | Q29615038 | ||
| Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis | Q33227757 | ||
| Cytomegalovirus: pathogen, paradigm, and puzzle | Q33351523 | ||
| De novo synthesis of VP16 coordinates the exit from HSV latency in vivo | Q33422983 | ||
| Evidence that herpes simplex virus VP16 is required for viral egress downstream of the initial envelopment event | Q33807388 | ||
| Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study | Q33880835 | ||
| An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle | Q33887700 | ||
| Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation | Q34109911 | ||
| Stress-inducible alternative translation initiation of human cytomegalovirus latency protein pUL138. | Q34120107 | ||
| A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection | Q34126265 | ||
| A review of genetic differences between limited and extensively passaged human cytomegalovirus strains | Q34263661 | ||
| Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee | Q34340674 | ||
| Coding potential of laboratory and clinical strains of human cytomegalovirus | Q34388908 | ||
| Do pathogens accelerate atherosclerosis? | Q34389205 | ||
| Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency | Q34415946 | ||
| Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment | Q34742654 | ||
| The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression. | Q35363103 | ||
| Report from the second cytomegalovirus and immunosenescence workshop | Q35568719 | ||
| Role of persistent CMV infection in configuring T cell immunity in the elderly | Q35696950 | ||
| Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle | Q35886438 | ||
| Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro | Q35901715 | ||
| Cytomegalovirus and atherosclerosis | Q63983739 | ||
| Structural changes in human cytomegalovirus cytoplasmic assembly sites in the absence of UL97 kinase activity | Q80006155 | ||
| Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women | Q81722105 | ||
| Chronic infection and frailty: surrogate markers, associations, and causality | Q81722129 | ||
| Congenital cytomegalovirus infection | Q85028491 | ||
| Interactions between proteins encoded within the human cytomegalovirus UL133-UL138 locus. | Q36172152 | ||
| An endogenous accelerator for viral gene expression confers a fitness advantage. | Q36555148 | ||
| The "silent" global burden of congenital cytomegalovirus | Q36558293 | ||
| The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. | Q36655446 | ||
| An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation | Q36667906 | ||
| Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site | Q36680389 | ||
| A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2 | Q36680417 | ||
| Discordant expression of the immediate-early 1 and 2 gene regions of human cytomegalovirus at early times after infection involves posttranscriptional processing events. | Q36688428 | ||
| Recent advances in the prevention and treatment of congenital cytomegalovirus infections | Q36743233 | ||
| Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency | Q36780729 | ||
| The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site | Q36796246 | ||
| The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97. | Q36827232 | ||
| Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression | Q36827546 | ||
| Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region | Q36828401 | ||
| Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. | Q36853873 | ||
| Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture | Q36885629 | ||
| Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus. | Q37191889 | ||
| Functional roles of the human cytomegalovirus essential IE86 protein | Q37219975 | ||
| Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. | Q37220026 | ||
| Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications | Q37677640 | ||
| Persistent viral infections and immune aging | Q37781508 | ||
| Role of CMV in immune senescence | Q37792338 | ||
| Human cytomegalovirus infection and atherothrombosis | Q37967568 | ||
| In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. | Q39031776 | ||
| Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection | Q39167516 | ||
| The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling | Q39462585 | ||
| A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency | Q39594664 | ||
| Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. | Q39872953 | ||
| Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes | Q39960937 | ||
| Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells | Q40065340 | ||
| Human Cytomegalovirus: Purification of Enveloped Virions and Dense Bodies | Q40092439 | ||
| A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1 | Q40106141 | ||
| The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis | Q40899518 | ||
| ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays | Q43536416 | ||
| Herpes simplex virus immediate early gene expression in the absence of transinduction by Vmw65 varies during the cell cycle | Q44315019 | ||
| Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. | Q45397798 | ||
| Genetic content of wild-type human cytomegalovirus | Q47709383 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytomegaloviral disease | Q2076966 |
| Cytomegalovirus | Q6946 | ||
| P304 | page(s) | 5987-6002 | |
| P577 | publication date | 2014-03-12 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Antagonistic determinants controlling replicative and latent states of human cytomegalovirus infection | |
| P478 | volume | 88 |
| Q92601877 | Alternative promoters drive human cytomegalovirus reactivation from latency |
| Q33887700 | An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle |
| Q92482120 | Cell Line Models for Human Cytomegalovirus Latency Faithfully Mimic Viral Entry by Macropinocytosis and Endocytosis |
| Q36736267 | Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency |
| Q34594796 | Complex expression of the UL136 gene of human cytomegalovirus results in multiple protein isoforms with unique roles in replication. |
| Q38272313 | Epigenetic regulation of human cytomegalovirus latency: an update |
| Q38796870 | Genetic Stability of Bacterial Artificial Chromosome-Derived Human Cytomegalovirus during Culture In Vitro. |
| Q33912815 | Human Cytomegalovirus Latency: Approaching the Gordian Knot |
| Q39100413 | Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells. |
| Q57469888 | Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency |
| Q35745418 | Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells |
| Q37300396 | Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency |
| Q58734475 | Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation |
| Q36027770 | Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication. |
| Q54593236 | Recent advances in CMV tropism, latency, and diagnosis during aging. |
| Q91510925 | The Golgi sorting motifs of human cytomegalovirus UL138 are not required for latency maintenance |
| Q47283029 | The loss of binary: Pushing the herpesvirus latency paradigm |
| Q40190061 | The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus |
| Q47574967 | Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency |
| Q59356089 | Virus Control of Trafficking from Sorting Endosomes |
Search more.